These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 11384635)
21. Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study. Hugues JN; Soussis J; Calderon I; Balasch J; Anderson RA; Romeu A; Hum Reprod; 2005 Mar; 20(3):629-35. PubMed ID: 15618252 [TBL] [Abstract][Full Text] [Related]
22. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial. Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040 [TBL] [Abstract][Full Text] [Related]
23. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial. Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535 [TBL] [Abstract][Full Text] [Related]
24. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group. Coelingh Bennink HJ; Fauser BC; Out HJ Fertil Steril; 1998 Jan; 69(1):19-25. PubMed ID: 9457926 [TBL] [Abstract][Full Text] [Related]
25. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group. J Clin Endocrinol Metab; 1998 May; 83(5):1507-14. PubMed ID: 9589647 [TBL] [Abstract][Full Text] [Related]
26. Recombinant versus urinary gonadotrophins for triggering ovulation in assisted conception. Al-Inany H; Aboulghar MA; Mansour RT; Proctor M Hum Reprod; 2005 Aug; 20(8):2061-73. PubMed ID: 16024539 [TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility. Balen AH; Mulders AG; Fauser BC; Schoot BC; Renier MA; Devroey P; Struijs MJ; Mannaerts BM J Clin Endocrinol Metab; 2004 Dec; 89(12):6297-304. PubMed ID: 15579793 [TBL] [Abstract][Full Text] [Related]
28. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic,chronic anovulation: a prospective randomized study. Yarali H; Bukulmez O; Gurgan T Fertil Steril; 1999 Aug; 72(2):276-81. PubMed ID: 10438995 [TBL] [Abstract][Full Text] [Related]
29. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. van Santbrink EJ; Fauser BC J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513 [TBL] [Abstract][Full Text] [Related]
30. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone? Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819 [TBL] [Abstract][Full Text] [Related]
31. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization. Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866 [TBL] [Abstract][Full Text] [Related]
32. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety. Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134 [TBL] [Abstract][Full Text] [Related]
33. Periovulatory serum human chorionic gonadotropin (hCG) concentrations following subcutaneous and intramuscular nonrecombinant hCG use during ovulation induction: a prospective, randomized trial. Sills ES; Drews CD; Perloe M; Kaplan CR; Tucker MJ Fertil Steril; 2001 Aug; 76(2):397-9. PubMed ID: 11476796 [TBL] [Abstract][Full Text] [Related]
34. Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation? Caserta D; Lisi F; Marci R; Ciardo F; Fazi A; Lisi R; Moscarini M Gynecol Endocrinol; 2011 Nov; 27(11):862-6. PubMed ID: 21391759 [TBL] [Abstract][Full Text] [Related]
35. Intrauterine insemination with recombinant or urinary human chorionic gonadotropin: A prospective randomized trial. Lorusso F; Palmisano M; Serratì G; Bassi E; Lamanna G; Vacca M; Depalo R Gynecol Endocrinol; 2008 Nov; 24(11):644-8. PubMed ID: 19031222 [TBL] [Abstract][Full Text] [Related]
36. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114 [TBL] [Abstract][Full Text] [Related]
37. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175 [TBL] [Abstract][Full Text] [Related]
38. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Bergh C; Howles CM; Borg K; Hamberger L; Josefsson B; Nilsson L; Wikland M Hum Reprod; 1997 Oct; 12(10):2133-9. PubMed ID: 9402268 [TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development. Krause BT; Ohlinger R Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065 [TBL] [Abstract][Full Text] [Related]
40. Successful pregnancies in patients with estrogenic anovulation after low-dose human chorionic gonadotropin therapy alone following hMG for controlled ovarian hyperstimulation. Lee KL; Couchman GM; Walmer DK J Assist Reprod Genet; 2005 Jan; 22(1):37-40. PubMed ID: 15807221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]